Webinars | Pharmaceuticals and Drug Discovery

Pharmaceuticals and Drug Discovery Webinars

Promoted Webinars

Ask the Experts: Instrument Validation and Data Regulation Solutions: IQ/OQ and 21 CFR Part 11 Compliance

Watch the webinar

Solutions to facilitate the development of CAR-NK cell therapy

Watch the webinar

On demand webinar: Using a handheld raman analyzer for quality testing in pharmaceutical manufacturing

Watch the webinar

Introducing the new portable XRF Analyzer for identity testing of pharmaceutical ionic salts

Watch the webinar

Pharmaceuticals and Drug Discovery Webinars

The continuous monitoring concept for pharmaceutical manufacturing

2 Nov 2023

Ask the Experts: Instrument Validation and Data Regulation Solutions: IQ/OQ and 21 CFR Part 11 Compliance

Compliant documentation in the drug manufacturing process is essential. 21 CFR Part 11 compliance software helps achieve this from raw materials to finished goods.  In addition, the qualifications of individual instruments benefit from software-supported functionality.

26 Jul 2023

Solutions to facilitate the development of CAR-NK cell therapy

In this webinar, Dr. Huo Tong will discuss the barriers associated with CAR-NK cell production and provide solutions to improve their development process.

24 Jun 2023

On demand webinar: Using a handheld raman analyzer for quality testing in pharmaceutical manufacturing

Handheld Raman spectrometers have fundamentally changed how the pharmaceutical industry performs incoming raw material identification.

22 Nov 2022

Introducing the new portable XRF Analyzer for identity testing of pharmaceutical ionic salts

This webcast explores the use of a portable x-ray fluorescence (XRF) instrument, the Thermo Scientific™ IonicX™, and explains how it can identify ionic salts in seconds and replace traditional time-consuming and resource-intensive wet chemistry and benchtop methods.

22 Nov 2022

Chemical Denaturants to Determine Aggregation Propensity

This webinar reviews light scattering-based methods for protein characterization and explain their utility, when combined with partially denaturing buffers, in understanding aggregation propensity of monoclonal antibodies (mAbs).

27 Oct 2021

Treatments of COVID-19: Old Drugs, New Tricks

COVID-19 is a global pandemic caused by the SARS-CoV-2 virus. There is a huge worldwide effort underway to discover vaccines and new drugs, and to repurpose old drugs to treat this disease.

3 Jun 2020

Unlocking Global Expedited Regulatory Schemes for Optimized Drug Development

The expedited schemes available from global regulatory bodies offer significant advantages for drug product developers. While the basic tenants of quality, safety and efficacy testing remain, such programs have been introduced to rapidly get cutting edge treatments to target patient populations.

30 May 2019

Biophysical and Stability Characterization of Antibody-Drug Conjugates

Antibody-Drug Conjugates (ADCs) are a rapidly growing class of oncology therapeutics wherein a potent cytotoxic drug is conjugated to the antibody molecule. The impact of drug conjugation on the antibody's conformation needs to be evaluated.

13 Sep 2018

Kinetic Characterization of Covalent Inhibitors

Kinetic Characterization of Covalent Inhibitors on the PHERAstar

7 Sep 2018

TR-FRET to Measure the Kinetics of Ligand-Receptor Binding

A TR-FRET approach to measuring the kinetics of ligand-receptor binding and its application of fragment screening

7 Sep 2018

Real-Time Profiling of Receptor Pharmacology

Receptor function is multifaceted and it is therefore highly advantageous to monitor multiple aspects in live cells and in real-time.

7 Sep 2018

The Kinetics of Drug Binding

Optimizing the receptor binding kinetics of new drugs can have significant benefits, including improved action duration and enhanced efficacy.

7 Sep 2018

Label-Free Techniques for Drug Discovery: Surface Plasmon Resonance (SPR) and MALDI Mass Spectrometry for Primary (HTS) and Secondary Screening

The webinar will update on latest developments in MALDI mass spectrometry for high-throughput screening and CPD profiling (rapifleX MALDI PharmaPulse) and introduce Bruker's new surface plasmon resonance (SPR) instrument, the SIERRA SPR-32.

13 Aug 2018

Label-Free High-Throughput MALDI TOF Mass Spectrometry in Drug Discovery

The presentation will give a current overview of label-free high-throughput MALDI TOF mass spectrometry and its use in drug discovery screening. It will explain the basics of MALDI TOF mass spectrometry and the benefits of label-free screening compared to current labeled approaches.

15 Aug 2017

Pharmaceuticals and Drug Discovery Webinars

Promoted Webinars

Pharmaceuticals and Drug Discovery Webinars

Webinar Categories

Webinar Services